CH Biotech R&D Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	640.73	394.13	478.86	939.93	530.02	321.01
Short-Term Investments	3.19	3.14	3.28	3.07	3.07	5.78
Cash & Short-Term Investments	643.92	397.27	482.13	943	533.1	326.79
Cash Growth	2.28%	-17.60%	-48.87%	76.89%	63.13%	-0.93%
Accounts Receivable	183.46	246.02	162.83	106.07	33.3	161.14
Other Receivables	56.04	53.59	56.62	44.8	42.97	29.13
Receivables	239.49	299.61	219.45	150.87	76.27	190.27
Inventory	179.89	153.48	122.1	119.21	177.26	125.01
Prepaid Expenses	26.33	18.93	26.5	18.59	12.99	10.74
Other Current Assets	2.18	2.31	2.4	3.76	4.07	1.71
Total Current Assets	1,092	871.59	852.59	1,235	803.69	654.53
Property, Plant & Equipment	2,631	2,631	2,718	2,361	2,365	2,349
Long-Term Investments	26.43	26	29.1	29.36	-	-
Goodwill	2.45	2.45	2.45	2.45	2.45	2.45
Other Intangible Assets	13.98	8.75	3.43	3.71	5.82	5.39
Long-Term Deferred Tax Assets	6.71	6.79	2.84	3.21	2	2.23
Other Long-Term Assets	33.24	27.59	20.7	14.37	16.08	15.24
Total Assets	3,805	3,574	3,629	3,649	3,195	3,029
Accounts Payable	4.79	9.04	8.84	9.26	9.62	20.71
Accrued Expenses	-	0.19	0.23	0.35	0.41	0.19
Short-Term Debt	590	365	290	190	120	188
Current Portion of Long-Term Debt	85.62	107.28	107.28	385.6	120	140.76
Current Portion of Leases	25.05	25.56	24.33	28.18	21.62	16.83
Current Income Taxes Payable	139.28	66.8	54.11	119.28	76.02	68.35
Current Unearned Revenue	0.08	0.17	0.32	0.47	0.3	0.35
Other Current Liabilities	157.86	147.47	161.82	149.19	119.56	93.66
Total Current Liabilities	1,003	721.51	646.93	882.32	467.52	528.84
Long-Term Debt	37.5	31.98	189.26	-	385.6	523.18
Long-Term Leases	130.19	134.5	136.46	241.38	247.66	253.51
Pension & Post-Retirement Benefits	-	-	7.2	5.36	4.26	-
Long-Term Deferred Tax Liabilities	-	-	2.38	-	2.56	-
Other Long-Term Liabilities	0.5	0.48	0.21	-	-	-
Total Liabilities	1,171	888.48	982.44	1,129	1,108	1,306
Common Stock	1,028	1,028	1,028	1,028	970.83	844.2
Additional Paid-In Capital	718.85	718.53	718.26	717.64	331.32	331.32
Retained Earnings	1,066	930.12	877.19	771.2	782.37	570.21
Comprehensive Income & Other	13.56	9.35	22.42	3.3	3.16	-22.52
Total Common Equity	2,635	2,686	2,646	2,520	2,088	1,723
Minority Interest	-	-	0.87	-	-	-
Shareholders' Equity	2,635	2,686	2,647	2,520	2,088	1,723
Total Liabilities & Equity	3,805	3,574	3,629	3,649	3,195	3,029
Total Debt	868.36	664.33	747.33	845.16	894.89	1,122
Net Cash (Debt)	-224.45	-267.05	-265.19	97.84	-361.79	-795.48
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.18	-2.59	-2.57	1.00	-3.67	-8.11
Filing Date Shares Outstanding	100.8	102.8	102.8	102.8	97.08	97.08
Total Common Shares Outstanding	100.8	102.8	102.8	102.8	97.08	97.08
Working Capital	89.14	150.08	205.66	353.1	336.16	125.69
Book Value Per Share	26.14	26.13	25.74	24.52	21.50	17.75
Tangible Book Value	2,618	2,675	2,640	2,514	2,079	1,715
Tangible Book Value Per Share	25.97	26.02	25.68	24.46	21.42	17.67
Land	503.59	502.39	546.51	143.24	143.26	109.81
Buildings	2,023	2,018	1,949	1,905	1,864	1,448
Machinery	971.29	892.56	823.54	576.15	476.33	358.65
Construction In Progress	53.18	35.68	40.12	60.5	73.28	508.86